Dr. Mohammad Akbar is a postdoctoral researcher in the division of bone urologic and reproductive products, Office of Clinical Pharmacology at the United States Food and Drug Administration (FDA). He is also an Assistant Professor in the Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Bangladesh. He received his doctoral degree in Pharmaceutical Sciences from the University of Florida, USA and discovered the treatment strategy focusing on estrogen deficiency-related bone loss using recombinant adeno associated virus vector and stem cells technology. He is an expert in the field of osteoporosis, bone metabolic and autoimmune disorders, clinical pharmacology, protein, gene and stem cells based therapeutics. Dr. Akbar’s 20 articles have been printed in the most stringent, and highly regarded, peer-reviewed journals including PloS One, Human Gene Therapy, and Molecular Medicine etc. He is also an author of five book chapters. He received many prestigious awards from many scientific societies including research award in biotechnology from the American Association of Pharmaceutical Scientists (AAPS) and a meritorious abstract award from the American Association of Gene and Cell Therapy (ASGCT), and is a member of these societies as well. Dr. Akbar received his B.S. in Pharmacy and M.S. in Clinical Pharmacy and Pharmacology from the University of Dhaka, Bangladesh. Following completion of his MS program, he started his career as a pharmaceutical scientist in pharmaceutical industry and later joined as a faculty at the University of Dhaka, Bangladesh. At that time, he carried out research on medicinal chemistry focusing on the discovery of antimicrobial and anticancer drugs. Dr. Akbar reviewed articles for Life Sciences, Annals of Orthopedic and Musculoskeletal Disorders and is a reviewer of Stem cell: Advance Research and Therapy.
Osteoporosis and bone metabolic disorders, autoimmune disorders, protein, gene, and stem cells-based drug delivery and therapy, clinical pharmacology, molecular biology and cell signaling.